PT2878306T - Péptido modificado, ligando do recetor cb, kit, processo in vitro para avaliação das ligações do recetor cb, utilizações, composição farmacêutica para modular a atividade do recetor cb - Google Patents

Péptido modificado, ligando do recetor cb, kit, processo in vitro para avaliação das ligações do recetor cb, utilizações, composição farmacêutica para modular a atividade do recetor cb

Info

Publication number
PT2878306T
PT2878306T PT13816344T PT13816344T PT2878306T PT 2878306 T PT2878306 T PT 2878306T PT 13816344 T PT13816344 T PT 13816344T PT 13816344 T PT13816344 T PT 13816344T PT 2878306 T PT2878306 T PT 2878306T
Authority
PT
Portugal
Prior art keywords
receptor
modulating
evaluating
kit
pharmaceutical composition
Prior art date
Application number
PT13816344T
Other languages
English (en)
Inventor
Sterman Heimann Andrea
Original Assignee
Proteimax Biotecnologia Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteimax Biotecnologia Ltda filed Critical Proteimax Biotecnologia Ltda
Publication of PT2878306T publication Critical patent/PT2878306T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT13816344T 2012-07-13 2013-07-12 Péptido modificado, ligando do recetor cb, kit, processo in vitro para avaliação das ligações do recetor cb, utilizações, composição farmacêutica para modular a atividade do recetor cb PT2878306T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102012174219 2012-07-13

Publications (1)

Publication Number Publication Date
PT2878306T true PT2878306T (pt) 2019-02-06

Family

ID=52997776

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13816344T PT2878306T (pt) 2012-07-13 2013-07-12 Péptido modificado, ligando do recetor cb, kit, processo in vitro para avaliação das ligações do recetor cb, utilizações, composição farmacêutica para modular a atividade do recetor cb

Country Status (3)

Country Link
EP (1) EP2878306B1 (pt)
DK (1) DK2878306T3 (pt)
PT (1) PT2878306T (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3800195A1 (en) * 2019-10-03 2021-04-07 Universitat de Barcelona Peptide compounds for reducing side effects of cb1 receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1929305A2 (en) * 2005-08-31 2008-06-11 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
EP2307443B1 (en) * 2008-08-07 2013-10-02 Yeda Research And Development Company Ltd. Affinity purification by cohesin-dockerin interaction
BRPI0902481B8 (pt) * 2009-07-31 2021-05-25 Soc Beneficente De Senhoras Hospital Sirio Libanes composição farmacêutica compreendendo hemopressina e seu uso.

Also Published As

Publication number Publication date
DK2878306T3 (en) 2019-03-04
EP2878306A1 (en) 2015-06-03
EP2878306B1 (en) 2018-11-07
EP2878306A4 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
PH12014501108A1 (en) Anti-il-36r antibodies
EP2905290A4 (en) HETERODIMER PROTEIN COMPOSITION
SG11201502238PA (en) Protein ligand for affinity isolation matrix
IL234203B (en) Neurotrophin-binding protein p75ntr for medical use
EP2873678A4 (en) PEPTIDE PENETRATING IN A CELL, CONJUGATED COMPRISING SAME, AND COMPOSITION COMPRISING SAME
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
PH12014502406A1 (en) Anti-il-23p19 antibodies
EP2690173A4 (en) PROTEIN FOR AFFINITY CHROMATOGRAPHY SEPARATION MATRIX
HUE054621T2 (hu) Gyógyászáti készítmény, kezelési eljárások és alkalmazásaik
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
BR112014022788A2 (pt) peptídeo, polipeptídeos, ácido nucleico, composição farmacêutica, conjugado e método in vitro
EP2874997A4 (en) NEW SIGMA RECEPTOR LIGANDS AND METHOD FOR REGULATING CELLULAR PROTEIN HOMEOSTASIS THEREWITH
IL236128A (en) Ruthenium bracelets, their use of metathesis reactions, and the process of performing the metathesis reaction
SG11201405578TA (en) Pharmaceutical composition containing peptide
EP2733156A4 (en) ORGANIC-INORGANIC COMPLEX AND COMPOSITION FOR THE FORMATION OF THIS COMPLEX
EP2889307A4 (en) ALPHA-CONOTOXIN PEPTIDE AND MEDICAL COMPOSITION AND THEIR OBJECTIVE
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
SG11201501536TA (en) Catalyst composition for hydrogenation and method for hydrogenation using the same
SG11201501532YA (en) Catalyst composition for hydrogenation and method for hydrogenation using the same
EP2680879A4 (en) PEPTID LINKERS FOR POLYPEPTIDE COMPOSITIONS AND APPLICATION METHOD THEREFOR
HK1204948A1 (en) Radiation-sterilization-resistant protein composition
HK1204556A1 (zh) 藥物組合物及使用該藥物組合物的準藥物化妝品
PT2878306T (pt) Péptido modificado, ligando do recetor cb, kit, processo in vitro para avaliação das ligações do recetor cb, utilizações, composição farmacêutica para modular a atividade do recetor cb
EP2818525A4 (en) ELECTRODEPOSITION COATING COMPOSITION AND CATALYST FOR ELECTRODEPOSITION COATING COMPOSITION
EP2930175A4 (en) NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF